Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation [Phase 2]
Phase 2 clinical trial assessing the diagnostic validity of [18F]FSPG PET for detecting acute rejection after heart or liver transplantation…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation [NA]
Clinical trial update for the OCS Liver PROTECT trial on preserving and assessing donor livers for transplantation; status completed with re…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating Immuncell-LC for patients undergoing liver transplantation has completed.
-
FDA approval · 2023-05-08FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for mycophenolate mofetil from Ascend Laboratories, LLC under ANDA203005.
-
CLINICAL_TRIALS research · 2023-05-03Clinical Trial Update: A Feasibility Study of Octreotide Infusion During Liver Transplant. [Phase 2]
A Phase 2 feasibility study evaluating octreotide infusion during liver transplantation, with conditions including liver transplantation and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-05-01FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus by Sandoz Inc., resulting in a supplemental approval for the generic product. Thi…
-
FDA approval · 2023-03-08FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Institutional LLC)
FDA issued a supplemental approval for mycophenolate mofetil in a filing by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation [Phase 2]
Phase 2 clinical trial evaluating ascorbic acid to prevent postreperfusion syndrome in liver transplantation.
-
FDA approval · 2022-12-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Lannett's generic mycophenolate mofetil, authorizing its market approval as a generic immunosupp…
-
CLINICAL_TRIALS withdrawal · 2022-12-14Clinical Trial Update: De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study [Phase 3]
A Phase 3 randomized trial comparing de novo everolimus versus tacrolimus (both with mycophenolate and low-dose corticosteroids) in liver tr…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation [NA]
Clinical trial update on biomarkers predicting successful tacrolimus withdrawal and everolimus monotherapy early after liver transplantation…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Relationship Between Serum Vitamin D and Outcomes of Liver Transplantation in Cirrhotic Patients Undergoing Liver Transplantation and Effects of Vitamin D Supplementation in Post-transplant Period [Phase 1, Phase 2]
A mixed Phase 1/2 clinical trial evaluating the relationship between serum vitamin D and outcomes after liver transplantation in cirrhotic p…
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation [Phase 4]
Phase 4 trial update on safety and efficacy of basiliximab with delayed-dose tacrolimus and ECMPA after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation [Phase 4]
Phase 4 trial update evaluating micafungin for prevention of invasive fungal infections after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: WP01 - Normothermic Liver Preservation [NA]
Clinical trial update for WP01 on normothermic liver preservation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation [Phase 2]
Phase 2 trial evaluating bevacizumab biosimilar with FOLFOX4 for recurrent hepatocellular carcinoma after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE [NA]
Clinical trial evaluating a bridge-to-transplant approach for hepatocellular carcinoma patients awaiting liver transplantation; study termin…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation. [Phase 4]
A Phase 4 clinical trial update evaluating two guided transfusion strategies and their effect on blood product usage in liver transplantatio…
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation [Phase 3]
Phase 3 clinical trial evaluating neo-adjuvant transarterial chemoinfusion for hepatocellular carcinoma patients beyond Milan/UCSF criteria …
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Randomized Controlled Trial to Study the Outcome of Intravenous Phosphate Supplementation in Live Donors Undergoing Hepatectomy for Living Donor Liver Transplantation (LDLT) [Phase 4]
Phase 4 randomized trial assessing intravenous phosphate supplementation for live donors undergoing hepatectomy in living donor liver transp…
-
FDA approval · 2021-10-22FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Cellcept (mycophenolate mofetil hydrochloride) submitted by Genentech, Inc.
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Mycophenolate mofetil from Ascend Laboratories, LLC under ANDA 203005, indicating approval of a …
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for a generic version of mycophenolate mofetil from Concord Biotech Limited.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation [NA]
A terminated clinical trial investigated the effect of nitric oxide on ischemia/reperfusion injury during extended donor criteria liver tran…
-
FDA approval · 2021-05-17FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for mycophenolate mofetil (ANDA 090253), allowing continued marketing of the gener…